Metastatic Ewing sarcoma/PNET of bone at diagnosis: Prognostic factors - A report from Saudi Arabia

Medical and Pediatric Oncology

Volumn 37, Issue 4, 2001, Pages 383-389

  Derek Jenkin, R ^a   Al Fawaz, Ibrahim ^a   Al Shabanah, Mohammed O ^a   Allam, Ayman ^a   Ayas, Mouhab ^a   Memon, Muhammad ^a   Rifai, Samira ^a   Schultz, Henrik P ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Childhood cancer; Ewing sarcoma; Metastatic bone tumors; PNET of bone; Prognosis

Indexed keywords

ADOLESCENT; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CANCER SURVIVAL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EWING SARCOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; METASTASIS; NEUROECTODERM TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; SAUDI ARABIA; TREATMENT INDICATION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; NEUROECTODERMAL TUMORS; ORTHOPEDIC PROCEDURES; PROGNOSIS; REGISTRIES; SARCOMA, EWING'S; SAUDI ARABIA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034793237     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1214     Document Type: Article

References (22)

1. Ewing's tumours with primary lung metastases: Survival analysis of 114 (European Intergroup) co-operative Ewing's sarcoma studies patients
2. Primary metastatic (stage 4) Ewing tumor: Survival analysis of 171 patients from the EICESS studies
3. Outcome in 43 children presenting with metastatic Ewing sarcoma: The St. Jude children's research hospital experience, 1962-1992
4. Ewing's saracoma metastatic at diagnosis: Results and comparisons of two intergroup Ewing's sarcoma studies
5. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: End results of POG #8346
6. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma
7. Very-high dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults
8. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round- cell tumors: A feasibility study at St. Jude children's research hospital
9. Long-term results from the First UKCCSG Ewing's tumour study (ET-1)
10. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The second United Kingdom children's cancer study group and the medical research council Ewing's tumor study
11. Multimodal therapy for the management of nonpelvic, localised Ewing's sarcoma of bone: Intergroup study IESS-II
12. Multimodal therapy for the management of localised Ewing's sarcoma of pelvic and sacral bones: A report from the second intergroup study
13. Adding iphosphamide and etoposide to vincristine, cyclophosphamide, adriamycin and actinomycin improves outcome in non-metastatic Ewing's and PNET: Update of CCG/POG study
14. Report from the European intergroup cooperative Ewing's sarcoma study (EICESS 92)
15. Prognostic significance of tumor volume in localised Ewing's sarcoma of bone in children and adolescents
16. Multimodal therapy for management of primary, nonmetastatic Ewing's sarcoma of bone: A long-term follow-up of the first intergroup study
17. Multimodal therapy for the management of nonpelvic, localised Ewing's sarcoma of bone: Intergroup study IESS-II
18. Multimodal therapy for the management of localised Ewing's sarcoma of pelvic and sacral bones: A report from the second intergroup study
19. Ewing's sarcoma: Prognosis and survival in mexican children from a single institution
20. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localised Ewing sarcoma of bone: The CESS 86 experience
21. The response to initial chemotherapy as a prognostic factor in localised Ewing's sarcoma